<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Clinical analysis was performed on anti-<z:chebi fb="0" ids="28494">cardiolipin</z:chebi> x beta2 <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> 1 (ACL x beta2 GP1) antibody positive patients with <z:e sem="disease" ids="C0262428" disease_type="Disease or Syndrome" abbrv="">collagen vascular diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Nine patients out of 89 showed positive aCL x beta2 GP1 antibody which was a relatively lower percentage compared to that of othoffanti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> antibodies, such as anti-<z:chebi fb="0" ids="28494">cardiolipin</z:chebi> antibody (23 out of 58), <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> anti-coagulant (15 out of 51) or biological false positive (BFP) test for <z:e sem="disease" ids="C0039128" disease_type="Disease or Syndrome" abbrv="">syphilis</z:e> (10 out of 50) </plain></SENT>
<SENT sid="2" pm="."><plain>However, 8 patients out of 9 with positive aCL x beta2 GP1 antibody showed thrombotic lesions, a relatively higher frequency compared to that seen in aCL x beta2 GP1 negative patients </plain></SENT>
<SENT sid="3" pm="."><plain>Among these cutaneous manifestations, <z:hpo ids='HP_0000965'>livedo reticularis</z:hpo> and palmar nodules with histopathological evidence of <z:mp ids='MP_0005048'>thrombosis</z:mp> were the most characteristic features </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> but one patient with palmar nodules showed positive aCL x beta2 GP1 antibody, anti-<z:chebi fb="0" ids="28494">cardiolipin</z:chebi> antibody and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> </plain></SENT>
</text></document>